Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Acumatica 2026 R1 brings AI-driven project risk tools to construction ERP as margin pressure intensifies
Why NUBURU, Inc.’s Phase I activation with Maddox Defense matters for U.S. defense supply-chain resilience (NYSE American: BURU)
Read More 6 minute read Pharma Industry News Can this A$653m raise turn PYC Therapeutics (ASX: PYC) into a global RNA frontrunner? PYC Therapeutics is raising A$653M to fund four RNA therapies into human efficacy trials. Find out what this means for investors and the biotech sector. bySrinathFebruary 2, 2026